Citadel Advisors
SKIN icon

Citadel Advisors’s SkinHealth Systems SKIN Stock Holding History

Citadel Advisors’s Portfolio SKIN Stock Details SKIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8K Buy
1,140
+15
+1% +$229 ﹤0.01% 13448
2026
Q1 		$20K Buy
1,125
+340
+43% +$8.35K ﹤0.01% 12672
2025
Q4 		$21.8K Sell
785
-810
-51% -$23.4K ﹤0.01% 12319
2025
Q3 		$63.5K Sell
1,595
-135
-8% -$5.48K ﹤0.01% 12081
2025
Q2 		$66.1K Buy
1,730
+1,230
+246% +$34.6K ﹤0.01% 11622
2025
Q1 		$13.4K Sell
500
-1,365
-73% -$41.6K ﹤0.01% 13401
2024
Q4 		$59.3K Buy
1,865
+630
+51% +$19.8K ﹤0.01% 12194
2024
Q3 		$35.6K Sell
1,235
-3,480
-74% -$114K ﹤0.01% 12272
2024
Q2 		$181K Sell
4,715
-4,970
-51% -$280K ﹤0.01% 10076
2024
Q1 		$860K Buy
9,685
+5,095
+111% +$331K ﹤0.01% 7242
2023
Q4 		$285K Buy
4,590
+2,340
+104% +$176K ﹤0.01% 9272
2023
Q3 		$271K Sell
2,250
-2,705
-55% -$380K ﹤0.01% 9345
2023
Q2 		$829K Sell
4,955
-4,210
-46% -$875K ﹤0.01% 6850
2023
Q1 		$2.32M Buy
9,165
+420
+5% +$97.1K ﹤0.01% 5081
2022
Q4 		$1.59M Sell
8,745
-6,840
-44% -$1.48M ﹤0.01% 5914
2022
Q3 		$3.67M Buy
15,585
+3,305
+27% +$836K ﹤0.01% 4406
2022
Q2 		$3.16M Buy
12,280
+2,960
+32% +$793K ﹤0.01% 4667
2022
Q1 		$3.15M Sell
9,320
-1,170
-11% -$386K ﹤0.01% 5069
2021
Q4 		$5.07M Buy
10,490
+5,480
+109% +$2.82M ﹤0.01% 4267
2021
Q3 		$2.6M Sell
5,010
-4,050
-45% -$1.78M ﹤0.01% 5712
2021
Q2 		$3.04M Buy
9,060
+2,425
+37% +$663K ﹤0.01% 5567
2021
Q1 		$1.43M Buy
+6,635
New +$1.46M ﹤0.01% 7219

Other funds holding SKIN

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors's SKIN Position: Q2 2026 in Review

Citadel Advisors increased its SkinHealth Systems (SKIN) stake by 296% in Q2 2026, buying an estimated $97.3K and bringing the position to 8,515 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #12551.

Citadel Advisors first reported a position in SKIN in Q1 2021 and has held it in 20 quarters since. The position peaked at $53M in Q2 2021. 93 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

  • Citadel Advisors held 8,515 shares of SkinHealth Systems worth $118K as of Q2 2026.
  • Citadel Advisors bought 6,366 SkinHealth Systems shares in Q2 2026, an estimated $97.3K.
  • SkinHealth Systems made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12551 holding.
  • Citadel Advisors first reported a position in SkinHealth Systems in Q1 2021 and has held it in 20 quarters since.
  • Citadel Advisors's SkinHealth Systems position peaked at $53M in Q2 2021.
  • 93 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.